The reverse is also true, with increases in fasting blood glucose and insulin levels leading to a higher overall prevalence of NAFLD, which is estimated to be 63–69% in patients with diabetes [18]–[20]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.